Back

Role of coronary calcium score and epicardial fat in stratifying baseline risk of cardiotoxicity in patients with gastrointestinal tumors

31 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Imaging in cardiovascular risk assessment (2) Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Cristina Madaudo

University of Palermo, Palermo (Italy)

7 More presentations in this session

Presentation thumbnail
Linking exercise-induced ventricular ectopy with subclinical myocardial damage in asymptomatic individuals
Professor U. Yuksel (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Higher disease activity and quality of life impairment are associated with increased carotid plaque in psoriatic arthritis patients
Doctor O. Garza Flores (Monterrey, MX)
Abstract Slides Video
Presentation thumbnail
Coronary inflammation as assessed by pericoronary adipose tissue (PCAT) attenuation in patients with and without standard modifiable cardiovascular risk factors (SMuRFs)
Mr S. Sivakumar (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Impact of the peri coronary artery inflammation and Ai based risk predictors using cardiac CTA on the stratification of patients with suspected CAD Insight from the NHS England Chest Pain Pilot
Miss N. Sanfeliu Garces (Milton Keynes, GB)
Abstract Slides Video
Presentation thumbnail
Utility of non-invasive MRI assessment of tenosynovial amyloidosis for early detection of cardiac amyloidosis: UNRAVEL, a pilot study
Mr M. Saldanha (Montreal, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging in cardiovascular risk assessment (2)

The Event

Event poster

ESC Congress 2025

31 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
The top EHJ papers in cardio-oncology
thumbnail
Congress Presentation
Current challenges in risk stratification of cancer therapy-related cardiovascular toxicity
thumbnail
Congress Presentation
Evaluation of the predictive value of the HFA-ICOS score for cardiotoxicity in breast cancer patients treated with anthracyclines and trastuzumab: a real-world observational study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources